• Inventors:
  • Assignees:
  • Publication Date: December 31, 1969
  • Publication Number:

Patent Citations (0)

    Publication numberPublication dateAssigneeTitle

NO-Patent Citations (0)

    Title

Cited By (32)

    Publication numberPublication dateAssigneeTitle
    CN-101932320-BJune 18, 2014开发邦宏膜融合抑制剂
    US-2003185912-A1October 02, 2003Rosenbloom Richard A.Anti-microbial compositions and methods of using same
    US-2005032895-A1February 10, 2005Yunik Chang, Robert Lathrop, Erwin Bohm, Irene Gander-Meisterernst, Ulrich Moebius, Johanna HolldackMedicament for the treatment of viral skin and tumour diseases
    US-2005079235-A1April 14, 2005Eggert StockflethUse of a polyphenol for the treatment of actinic keratosis
    US-2005148658-A1July 07, 2005Charles HensleyMethod for preventing and treating severe acute respiratory syndrome
    US-2006069046-A1March 30, 2006Burdick David C, Heinz Egger, Gum Andrew G, Ingo Koschinski, Elena Muelchi, Isabelle Prevot-HalterProcess for the production of (-)-epigallocatechin gallate
    US-2007059387-A1March 15, 2007Medigene AgUse of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin
    US-2007225315-A1September 27, 2007Theralogics, Inc.Methods of Treating Muscular Wasting Diseases Using NF-kB Activation Inhibitors
    US-2008075765-A1March 27, 2008Bukowski Jack F, Jeffrey WaltersMethods and materials for reducing risk of cold and/or flu
    US-2011003889-A1January 06, 2011Kunihiro KAIHATSUMembrane fusion inhibitor
    US-2011166219-A1July 07, 2011Medigene AgUse of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin
    US-2013035381-A1February 07, 2013Daisuke Ejima, Sato Haruna, Hajime Koyama, Tsutomu ArakawaVirus-inactivating composition containing low-molecular weight compound and arginine
    US-5470565-ANovember 28, 1995Mitsui Norin Co., Ltd.Composition for strengthening acid resistancy of teeth
    US-5670154-ASeptember 23, 1997Mitsui Norin Co., Ltd.Reducing tyrosinase activity
    US-5776462-AJuly 07, 1998Sage R&D, A PartnershipPogostemon cablin extract for inhibiting H. influenzae adhesion and treating otitis media or sore throat
    US-6248346-B1June 19, 2001Mitsui Norin Co., Ltd.Chewing gum and production of the same
    US-7312199-B2December 25, 2007Dsm Ip Assets B.V.Process for the production of (−)-epigallocatechin gallate
    US-7396546-B2July 08, 2008The Quigley CorporationAnti-microbial compositions and methods of using same
    US-7858662-B2December 28, 2010Medigene AgMedicament for the treatment of viral skin and tumour diseases
    US-7910138-B2March 22, 2011Medigene AgUse of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin
    US-8426355-B2April 23, 2013Theralogics, Inc.Methods of treating muscular wasting diseases using NF-κB activation inhibitors
    US-8455022-B2June 04, 2013Medigene AgUse of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin
    US-8465782-B2June 18, 2013Immune Guard, LLCMethods and materials for reducing risk of cold and/or flu
    US-8952055-B2February 10, 2015Protectea, Ltd.Membrane fusion inhibitor
    US-9060998-B2June 23, 2015Medigene AgUse of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin
    US-9173920-B2November 03, 2015Theralogics, Inc.Methods of treating muscular wasting diseases using NF-KB activation inhibitors
    US-9770406-B2September 26, 2017Medigene AgMedicament for the treatment of viral skin and tumour diseases
    US-9801850-B2October 31, 2017Osaka UniversityAntibacterial agent
    US-9872499-B2January 23, 2018Ajinomoto Co., Inc.Virus-inactivating composition containing low-molecular weight compound and arginine
    WO-2007106675-A2September 20, 2007Matthias Rath, Vadim Ivanov, Aleksandra Niedzwiecki, Waheed Roomi, Raxit JariwallaComposition et procede de retardement d'activite virale et reduction de replication virale
    WO-2007106675-A3December 06, 2007Matthias Rath, Vadim Ivanov, Aleksandra Niedzwiecki, Waheed Roomi, Raxit JariwallaComposition and method of retarding viral activity and reducing viral replication
    WO-2007139350-A1December 06, 2007Protheon Co., Ltd, Nutrex Technology Co., LtdAgent destiné à la prévention et au traitement de l'infection par le virus de l'influenza, comprenant des composés dérivés de la cathéchine